9,580.3090.2
Stock Analysis, IPO, Mutual Funds, Bonds & More

Anand Mahindra, Kiran Mazumdar-Shaw in awe of the 'woman behind India's first coronavirus testing kit'

Hours before delivering her baby, Minal Dakhave Bhosale had submitted the COVID-19 kits for evaluation.

ET Online and Agencies|
Last Updated: Mar 28, 2020, 02.09 PM IST
0Comments
Minal Dakhave Bhosale​' brave story stole Anand Mahindra and Kiran Mazumdar-Shaw's hearts.
Minal Dakhave Bhosale' brave story stole Anand Mahindra and Kiran Mazumdar-Shaw's hearts.
NEW DELHI: Mylabs Discovery Solutions that received a commercial approval from the Central Drugs Standard Control Organisation on Monday for its COVID-19 test kit is in news again. But, this time, it is for one of their virologists - Minal Dakhave Bhosale - who was heading the team that was working on coronavirus testing kit called 'Mylab PathoDetect COVID-19 Qualitative PCR kit'.

On Saturday, BCC featured a story, titled 'Coronavirus: The woman behind India's first testing kit', on the research and development chief of the Pune-based company.

The story spoke about how Bhosale fought a professional and personal deadline of delivering the functional kits on time along with pregnancy emergencies and due date approaching closer. A day before delivering her baby girl, she submitted her kits to the state-run National Institute of Virology (NIV) for evaluation.

Her brave story stole hearts of the India Inc bosses.

Anand Mahindra lauded Bhosale's efforts. Quoting the news of the virologist, the Mahindra Group Chairman wrote, "You also delivered a ray of hope to the country".

Kiran Mazumdar-Shaw, Chairperson and MD of Biocon, also praised the woman behind India's first testing kit. In her tweet, she wrote, Bhosale 'makes us all so proud to see women leading the way.

In a reply to her tweet, Mylabs wrote, "A leader is one who knows the way, goes the way, and shows the way. For all women here, you have been that inspiration!" Later, the molecular diagnostic company thanked the biotech entrepreneur for being an inspiration to all women and men at the firm.

In what may go down as an important solution in India's fight against coronavirus, the biotech company on Tuesday created an indigenous solution to test patients for COVID-19 that can halve the time taken for results. It was able to shorten the test time to 2.5 hours with the PathoDetect as against the prevalent 6-8 hours because its team has created a solution that does both the screening and confirmation jobs simultaneously.

According to PTI's news report, Mylab's team of 25 scientists started working on the solution six weeks ago, fearing that the crisis may eventually hit India.

The test for COVID-19 will also pick up positive cases among asymptomatic patients. The company that started off as a trading firm in 2012 and diversified into research in 2016 can manufacture over 15,000 testing kits per day from its facility at Lonavala and the same will be ramped up to 25,000 kits per day, its co-founder Shrikant Patole told PTI.

Agencies
​Minal Dakhave Bhosale​ heads the team that is working on coronavirus testing kit called 'Mylab PathoDetect COVID-19 Qualitative PCR kit'.​
Minal Dakhave Bhosale heads the team that is working on coronavirus testing kit called 'Mylab PathoDetect COVID-19 Qualitative PCR kit'. (Image: LinkedIn)

Patole had explained that till now, India has been using kits prepared by NIV, also based in Pune, but it was the fears over the increase in numbers which made private sector interventions in manufacturing necessary. The testing kits done by NIV cost up to Rs 4,500 per sample if both screening and confirmation are included. "Mylabs is confident of selling the kits at a fourth of that cost," he added. The company is looking to rope in investors.

Amitabh Kant, CEO of Niti Aayog, had also congratulated the Pune firm for the 'brilliant work' of developing a low-cost kit to detect COVID-19.



The War Against Coronavirus: Pichai, Jack Ma, Ambani & Other Top Bosses Show The Way

of 21
Next
Prev
Play Slideshow

Ma’s The Word

25 Mar, 2020
Chinese billionaire Jack Ma (C) showed his benevolent side as he pitched in to help the world fight the novel coronavirus. The founder of e-commerce major, Alibaba, Ma became the most talked about business figure after he said that he would marshall all available resources at his disposal to take on Covid-19. From donating emergency supplies (1.8M masks, 210K test kits, 36K protective suits, plus ventilators & thermometers) to Afghanistan, Bangladesh, Cambodia, Nepal, Pakistan & Sri Lanka in Asia to donating 20,000 test kits, 100,000 masks and 1,000 medical use protective suits in each of the 54 African countries, the 55-year-old proved that he was a good Samaritan whose charity was not mapped by geographical boundaries. And even as the business magnate didn’t have India in his list of beneficiaries, there was much talk in the country about his act of generosity. And what followed were natural questions: who among India’s rich was doing a Jack Ma?And it’s not just one individual, but a bunch of lion-hearted boardroom tycoons who have taken the pledge to help fight the virus that has thrown life off-track, in India and across the world.
Next

Also Read

States tap private companies for coronavirus testing kits

Jack Ma's coronavirus testing kits reach Nigeria

China says Indian criticism of coronavirus test kits is "irresponsible"

U.S. agency investigating production of faulty coronavirus test kits

Comments
Add Your Comments
Commenting feature is disabled in your country/region.

Popular Categories


Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service